RusnanoMedInvest and Domain Associates Invest In Neurology Company Marinus Pharmaceuticals

January 7, 2013

Marinus Pharmaceuticals announced $21 million in new Series C financing from U.S. venture capital firm Domain Associates, LLC, Rusnano subsidiary RusnanoMedInvest (RMI), and co-investors.
More »

RUSNANO and Domain Associates Announce First Joint Investment

July 25, 2012

RUSNANO and Domain Associates announced their first joint investment under a joint agreement reached in March. They will jointly invest in nearly $40 million in San Diego-based CoDa Therapeutics.
More »

RUSNANO and Domain Collaborate On Investments in Health Sciences Projects

March 6, 2012

RUSNANO and Domain Associates announced a partnership that will spur modernization of the Russian healthcare market by brining next-generation pharmaceuticals, medical devices and diagnostics to Russia.
More »